EHV-1 GP2 (C-Term) antibody

Details for Product No. ABIN966048
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Herpes simplex Virus (HSV)
Immunohistochemistry (IHC)
Pubmed 3 references available
Catalog no. ABIN966048
Quantity 0.1 mg
452.38 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 5 to 7 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of Wild-type equine herpesvirus 1 (EHV-1) glycoprotein, gp2
Background Wild-type equine herpesvirus 1 (EHV-1) strains express a large (250-kDa) glycoprotein, gp2, that is encoded by EUs4 (gene 71) located within the unique short region of the genome. The expression of full-length gp2 restore full respiratory virulence to the attenuated strain.
Restrictions For Research Use only
Product cited in: Learmonth, Love, Gilkerson et al.: "Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model." in: Archives of virology, Vol. 148, Issue 9, pp. 1805-13, 2003 (PubMed).

von Einem, Wellington, Whalley et al.: "The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11." in: Journal of virology, Vol. 78, Issue 6, pp. 3003-13, 2004 (PubMed).

Smith, Kahan, Rorex et al.: "Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice." in: Journal of virology, Vol. 79, Issue 8, pp. 5105-15, 2005 (PubMed).

Hosts (1)
Reactivities (1)
Applications (1)
Epitopes (1)
back to top